Visit Us @
Synergy Centre TU Dublin, Tallaght, D24A386
Mail Us @
info@codlad.com
Call Us @
+353 851890752

Archive for May 12, 2023

FDA Roundup: May 12, 2023

May 12, 2023

FDA Roundup: May 12, 2023

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated information on medical…

FDA Roundup: May 12, 2023 FDA
FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause

May 12, 2023

FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause

Today, the U.S. Food and Drug Administration approved Veozah (fezolinetant), an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot flashes,…

FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause FDA

Latest Posts

FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
March 25, 2026
FDA Schedules Public Meeting on the Commissioner’s National Priority Voucher Pilot Program
FDA Schedules Public Meeting on the Commissioner’s National Priority Voucher Pilot Program
March 20, 2026
FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide
FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide
March 19, 2026